A new study, published in the New England Journal of Medicine, found that 63 percent of multiple myeloma patients have a reduced risk of disease progression or death if treated with lenalidomide (Revlimid®) following a stem cell transplant. The study was co-authored by Richard Mariarz, MD, medical director of the Adult Stem Cell Transplantation Program & Center for Hematologic Malignancies at the Knight Cancer Institute. Read the OHSU News Release to learn more.
Posts Tagged ‘publications’
Two OHSU researchers, Fay Horak, Ph.D., professor of neurology, and Robert Peterka, Ph.D., associate professor of biomedical engineering, were recently recognized by the American Physiological Society for having highly cited publications in the Journal of Neurophysiology. Dr. Horak’s paper, “Central programming of postural movements: Adaptation to altered support-surface configurations,” was one of the top ten cited papers from 1980-1989, and Dr. Peterka’s, “Sensorimotor integration in human postural control,” was one of the top ten from 2000 to 2011. … Read More